WASHINGTON, May 17 (Reuters) - U.S. health officials on Wednesday warned that tests made by Meridian Bioscience Inc may underestimate lead levels in blood drawn from veins, sending the manufacturer's stock down 9 percent.
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
No comments:
Post a Comment